<DOC>
	<DOCNO>NCT00899223</DOCNO>
	<brief_summary>As one nation 's large cooperative cancer treatment group , Alliance Clinical Trials Oncology ( Alliance ) unique position organize Leukemia Tissue Bank . The member institution diagnose hundred patient leukemia myelodysplastic syndrome year , uniformly treat patient chemotherapy regimen . The Alliance offer centralize data management clinical history , classification leukemia myelodysplastic syndrome , cytogenetics , flow cytometric analysis , treatment follow-up . The highly skilled health care provider member institution familiar obtain informed consent , complete data questionnaire ship specimen . There currently exist central process facility sample prepare variety cellular molecular study . Hence , patient resource , health care provider , process facility Leukemia Tissue Bank place . What need , however , address current protocol , formal mechanism procure bone marrow , blood normal tissue patient hematologic malignancy enrol Alliance ( Cancer Leukemia Group B [ CALGB ] ) treatment study .</brief_summary>
	<brief_title>Collecting Storing Blood , Bone Marrow , Other Samples From Patients With Acute Leukemia , Chronic Leukemia , Myelodysplastic Syndromes</brief_title>
	<detailed_description>The objective study collect store specimen every newly diagnose patient acute chronic leukemia myelodysplastic syndrome ( MDS ) enter CALGB protocol previously untreated patient . Bone marrow aspirate blood specimen obtain patient diagnosis , remission , relapse store . Buccal smear obtain diagnosis , DNA extract preserve . It anticipate specimen collect protocol would use large number investigator . This protocol describe detail approve project ( eg , eligibility age range ) .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>Previously untreated patient CALGB treatment protocol leukemia ( acute chronic ) myelodysplasia eligible . Patients must register CALGB 9665 prior receive therapy disease . Signed informed consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>